Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL CHOLERA VACCINE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cholera Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cholera Vaccine Market by Vaccine Type
3.3.1: Whole Cell V. Cholerae O1 with Recombinant B-Subunit
3.3.2: Killed Oral O1 and O139
3.4: Global Cholera Vaccine Market by Product
3.4.1: Dukoral
3.4.2: Shanchol
3.4.3: Vaxchora
3.4.4: Euvichol and Euvichol-Plus
3.4.5: Others
3.5: Global Cholera Vaccine Market by End Use Industry
3.5.1: Hospitals and Clinics
3.5.2: Research and Academic Laboratories
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Cholera Vaccine Market by Region
4.2: North American Cholera Vaccine Market
4.2.2: North American Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
4.3: European Cholera Vaccine Market
4.3.1: European Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
4.3.2: European Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
4.4: APAC Cholera Vaccine Market
4.4.1: APAC Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
4.4.2: APAC Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
4.5: ROW Cholera Vaccine Market
4.5.1: ROW Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
4.5.2: ROW Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cholera Vaccine Market by Vaccine Type
6.1.2: Growth Opportunities for the Global Cholera Vaccine Market by Product
6.1.3: Growth Opportunities for the Global Cholera Vaccine Market by End Use Industry
6.1.4: Growth Opportunities for the Global Cholera Vaccine Market by Region
6.2: Emerging Trends in the Global Cholera Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cholera Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cholera Vaccine Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Astellas Pharma
7.2: Celldex Therapeutics
7.3: Emergent BioSolutions
7.4: Eubiologics
7.5: Johnson & Johnson
7.6: Merck
7.7: Pfizer
7.8: PharmaChoice Canada
7.9: Sanofi
7.10: Takeda Pharmaceutical Company Limited
2. GLOBAL CHOLERA VACCINE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cholera Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cholera Vaccine Market by Vaccine Type
3.3.1: Whole Cell V. Cholerae O1 with Recombinant B-Subunit
3.3.2: Killed Oral O1 and O139
3.4: Global Cholera Vaccine Market by Product
3.4.1: Dukoral
3.4.2: Shanchol
3.4.3: Vaxchora
3.4.4: Euvichol and Euvichol-Plus
3.4.5: Others
3.5: Global Cholera Vaccine Market by End Use Industry
3.5.1: Hospitals and Clinics
3.5.2: Research and Academic Laboratories
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Cholera Vaccine Market by Region
4.2: North American Cholera Vaccine Market
4.2.2: North American Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
4.3: European Cholera Vaccine Market
4.3.1: European Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
4.3.2: European Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
4.4: APAC Cholera Vaccine Market
4.4.1: APAC Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
4.4.2: APAC Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
4.5: ROW Cholera Vaccine Market
4.5.1: ROW Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
4.5.2: ROW Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cholera Vaccine Market by Vaccine Type
6.1.2: Growth Opportunities for the Global Cholera Vaccine Market by Product
6.1.3: Growth Opportunities for the Global Cholera Vaccine Market by End Use Industry
6.1.4: Growth Opportunities for the Global Cholera Vaccine Market by Region
6.2: Emerging Trends in the Global Cholera Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cholera Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cholera Vaccine Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Astellas Pharma
7.2: Celldex Therapeutics
7.3: Emergent BioSolutions
7.4: Eubiologics
7.5: Johnson & Johnson
7.6: Merck
7.7: Pfizer
7.8: PharmaChoice Canada
7.9: Sanofi
7.10: Takeda Pharmaceutical Company Limited
